Cargando…
Mechanism of protective effect of xuan-bai-cheng-qi decoction on LPS-induced acute lung injury based on an integrated network pharmacology and RNA-sequencing approach
Xuan-bai-cheng-qi decoction (XCD), a traditional Chinese medicine (TCM) prescription, has been widely used to treat a variety of respiratory diseases in China, especially to seriously infectious diseases such as acute lung injury (ALI). Due to the complexity of the chemical constituent, however, the...
Autores principales: | Zhu, Huahe, Wang, Shun, Shan, Cong, Li, Xiaoqian, Tan, Bo, Chen, Qilong, Yang, Yunxiang, Yu, Hongji, Yang, Aidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237774/ https://www.ncbi.nlm.nih.gov/pubmed/34183011 http://dx.doi.org/10.1186/s12931-021-01781-1 |
Ejemplares similares
-
Total extract of Xin Jia Xuan Bai Cheng Qi decoction inhibits pulmonary fibrosis via the TGF-β/Smad signaling pathways in vivo and in vitro
por: Qin, Hui, et al.
Publicado: (2019) -
Effectiveness of Xin Jia Xuan Bai Cheng Qi Decoction in treating acute exacerbation of chronic obstructive pulmonary disease: study protocol for a multicentre, randomised, controlled trial
por: Jin, Jin, et al.
Publicado: (2019) -
Tissue Pharmacology of Da-Cheng-Qi Decoction in Experimental Acute Pancreatitis in Rats
por: Zhao, Xianlin, et al.
Publicado: (2015) -
Xuan Bai Cheng Qi formula as an adjuvant treatment of acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs: a multicenter, randomized, double-blind, placebo-controlled clinical trial
por: Liu, Miao, et al.
Publicado: (2014) -
Da-Cheng-Qi Decoction Combined with Conventional Treatment for Treating Postsurgical Gastrointestinal Dysfunction
por: Jin, Wei, et al.
Publicado: (2017)